Dozens volunteer for live HIV injections
September 22, 1997
Web posted at: 9:24 p.m. EDT (2124 GMT)
LOS ANGELES (CNN) -- Dozens of doctors, nurses and health
policy activists have volunteered to be injected with a
weakened form of the HIV virus, saying they are willing to
risk their lives to speed up development of a vaccine that
could protect against AIDS.
One of the prime movers behind the volunteer drive, Dr.
Charles Farthing of the AIDS Healthcare Foundation, said he
will present his proposal for the trial by the International
Association of Physicians in AIDS Care (IAPAC) to an
international conference in November.
The volunteers hope that a live, weakened vaccine containing
the HIV virus may be developed and used in the same way
vaccinations against the measles, mumps and chicken pox are
in use today.
They argue that research into creating an HIV vaccine has
been too slow, because scientists have incorrectly assumed
that no one would risk his or her life to volunteer for a
human experiment.
IAPAC announced this weekend that it has 50 volunteers
willing to take part in the study, and dozens more calling in
to participate.
AIDS vaccine development is a slow process because of the
safety measures and rigorous animal testing needed before
injecting humans with a trial vaccine.
Research in the past decade has focused on vaccines that do
not involve a live strain of the human immunodeficiency virus
because of fear that even a weakened strain might cause AIDS
or other complications.
The group has said it may try to conduct the tests on its
own, without federal approval, by limiting the experiments to
a single U.S. state or going overseas.
But several scientists were skeptical that the proposed human
experiments could lead to a vaccine.
"I admire them," Dr. Mark Grabowsky of the National Institute
of Allergy and Infectious Diseases told the Chicago Tribune.
"That kind of activism can't help but be inspiring. But the
scientific questions still remain."
The Chicago-based IAPAC would like experiments to begin as
early as within the next 12 months, Farthing told CNN.
"We have the vaccine, we have initial safety data, we now
have highly active anti-retroviral therapy which can suppress
HIV if it misbehaves," said Farthing, who has volunteered for
the study. "So to me, the time would seem right."
The group would like to inject volunteers with a vaccine that
Dr. Ronald Desrosiers of Harvard Medical School has used with
monkeys.
Desrosiers told the Chicago Tribune that it is not possible
to create a 100 percent safe vaccine. But his vaccine seems
to protect monkeys from the primate-equivalent of HIV.
In one study, four monkeys injected with a version of
Desrosiers' vaccine and then exposed to the
primate-equivalent of HIV remained healthy, the newspaper
reported.
However, other combinations of the vaccine have made test
monkeys ill.
Another Harvard researcher, Dr. Ruth Ruprecht, found that 90
percent of a group of monkeys injected with a live anti-AIDS
vaccine at birth are showing early stages of the disease, and
half have full-blown AIDS, the newspaper said.
But IAPAC volunteers said that while there may be risks, they
understood them clearly and believed the risks were worth
taking.
"There are millions of lives going by while we sit around
debating the research," said Gordon Nary, the group's
director and one of the volunteers.
143K/6 sec. AIFF or WAV sound